Newsletter | March 24, 2020

03.24.20 -- Novel Method Of Phage Display Paves Way For New Peptide-Based Therapeutics

  Pharmacokinetic Strategies In CNS Drug Discovery

The discovery and clinical development of drugs for many Central Nervous System (CNS) disorders have remained elusive despite the dramatic increase in our understanding of the CNS over the last two decades. New drugs targeting important CNS diseases have higher failure rates than the other diseases, both preclinically and clinically. This article discusses successful PK approaches employed by GVK Bio in the recent past that may help in CNS targeted drug discovery and development efforts.

Industry Insights
Converting From ELISA To Biacore SPR Assays
Application Note | GE Healthcare Life Sciences

This article provides general guidance on how to convert an existing ELISA assay to a Biacore SPR-assay and by doing so, shows how you can get results in less than half the time compared with ELISA.

The Criticality Of API CDMO Selection: Insights From A Client
Case Study | Thermo Fisher Scientific

Small and emerging companies face challenges related to limited funding and resources, such as technical expertise and capacity, making it imperative they find a competent partner to support them.

Most Popular News
Life Science Leader Magazine

Have you heard of Life Science Leader?
Check it out today for access to candid interviews with top-tier executives on how they do business.